The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer

The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer

Breast cancer (BRCA) remains the most prevalent cancer worldwide and the tumor microenvironment (TME) has been discovered to exert a wide influence on the overall survival and therapeutic response. Numerous lines of evidence reported that the effects of immunotherapy of BRCA were manipulated by TME....

Full description

Bibliographic Details
Main Authors: Rongling Zhao, Wenkang Wang, Limin Pan, Xuefeng Lv, Yi He, Wenping Lian, Yajie Ma, Xinyu Zhang, Ruijing Yu, Shuai Zhao, Xiaona Guo, Tao Huang, Mengle Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
immunogenic cell death
breast cancer
prognosis
genes
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1047973/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1047973/full

Similar Items